S100A9 and colonic neoplasm: Sikert et al quantified TAM by immunohistochemistry with antibodies to PG-M1, KP-1, MRP8, MRP14 and MRP8/14 antigens and found different TAM subpopulation were positively correlated with clinicopathological characteristics in colon cancer [74].